Genistein: the future of prevention and treatment of breast cancer?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Endogenous estrogens-breast cancer and chemoprevention.Pharmacological reports : PR · 2021
   Review
2. Dietary Phytoestrogens Ameliorate Hydrochloric Acid-Induced Chronic Lung Injury and Pulmonary Fibrosis in Mice.Nutrients · 2021
   Article
3. In vitro study on anti-cancer properties of genistein in tongue cancer.OncoTargets and therapy · 2017
   Article
4. Cancer prevention and therapy through the modulation of the tumor microenvironment.Seminars in cancer biology · 2015
   Review
5. Genistein-induced mir-23b expression inhibits the growth of breast cancer cells.Contemporary oncology (Poznan, Poland) · 2015
   Article
6. Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.Anti-cancer agents in medicinal chemistry · 2012
   Review

Corrections and comments

• Comment on
  Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer.2011

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as